ZoomMed inc.

ZoomMed inc.

April 29, 2010 07:31 ET

ZoomMed: A 243% Increase in Revenues

MONTREAL, QUEBEC--(Marketwire - April 29, 2010) - ZoomMed Inc. (TSX VENTURE:ZMD), designer of the ZRx Prescriber, the e-Pic Communication Network and the ZRx Pharma Communication Network recently released its Financial Statements for the nine (9) month period ended February 28, 2010. We are proud to announce that ZoomMed Communication Networks have gained notoriety, proving beyond any doubt that we have valuable communication systems, which are appreciated by physicians and other health care organization.

"The Company reports revenues of $991,554 and deferred revenues of $1,196,083 totalling $2,187,637 for the nine (9) month period ended February 28, 2010, compared respectively with $467,200 and $434,375 totalling $901,575 for the same 2009 period. It represents a 242.65% increase, mainly related to ZRx Pharma Communication Network agreements signed by pharmaceutical corporation ", said Mr. Marmet.

About the ZRx Prescriber

ZoomMed developed the ZRx Prescriber, a technologically innovative Web application that enables physicians to use a wireless device, such as the IPod Touch™, IPhone™, other PDA's or computers, to rapidly write and deliver scripts. The ZRx Prescriber is quick, efficient and intuitive. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).

About the e-Pic Communication Network

ZoomMed's e-Pic Communication Network allows intercommunications between physicians who use the ZRx Prescriber, pharmacists and other organisations who are members of the network. Thus, physicians, pharmacists and other organisations can transfer, capture (scan), and electronically receive prescription information, renewals and referral information through this high speed and entirely secure network.

About the ZRx Pharma Communication Network

ZRx Pharma Communication Network, the new revolutionary communication tool, allows information dissemination and intercommunication between pharmaceutical corporations and physicians using the ZRx Prescriber, such as; continuing medical education, new product launches, medical training, major medical alerts, clinical studies and surveys.

The TSX Venture Exchange does not assume any responsibility for the adequacy or accuracy of this press release.

Contact Information